Stratos Wealth Partners’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Stratos Wealth Partners’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-350	Closed	-$39K	–	1483
2018 Q3	$39K	Buy	+350	New	+$37K	﹤0.01%	1561
2018 Q2	–	Sell	-350	Closed	-$35K	–	1607
2018 Q1	$35K	Buy	+350	New	+$37.7K	﹤0.01%	1768

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Stratos Wealth Partners's LKFT Position: Q4 2018 in Review

Stratos Wealth Partners sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2018, closing a stake of 350 shares — an estimated $39K sold.

Stratos Wealth Partners first reported a position in LKFT in Q1 2018 and held it in 2 quarters. The position peaked at $39K in Q3 2018. 85 funds tracked by Wall St. Rank hold LKFT as of Q4 2018.

Stratos Wealth Partners reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2018 after selling out during the quarter.
Stratos Wealth Partners sold 350 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2018, an estimated $39K.
Stratos Wealth Partners first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2018 and held it in 2 quarters.
Stratos Wealth Partners's Lakefront Biotherapeutics American Depositary Shares position peaked at $39K in Q3 2018.
85 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2018.

Based on Stratos Wealth Partners's 13F filing for Q4 2018, filed 8 Feb 2019.